Deepika Pakianathan - May 21, 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Matthew T. Potter, Attorney-in-Fact for Deepika Pakianathan
Stock symbol
KPTI
Transactions as of
May 21, 2021
Transactions value $
$0
Form type
4
Date filed
5/21/2021, 05:35 PM
Next filing
Jun 14, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +23.9K $0.00 23.9K May 21, 2021 Common Stock 23.9K $9.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on the earlier of May 21, 2022 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc. (the "Issuer"), provided that the reporting person continues to serve as a director of the Issuer through such date.